trending Market Intelligence /marketintelligence/en/news-insights/trending/uccgmBdW3vDdL4elS0-ZwA2 content esgSubNav
In This List

Loxo Oncology names chief development officer, COO

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Loxo Oncology names chief development officer, COO

Loxo Oncology Inc. promoted Nisha Nanda to the post of chief development officer and changed Jacob Van Naarden's title to COO, effective Jan. 2.

Nanda previously worked as senior vice president of development strategy from January 2017 to December 2018 at the Stamford, Conn.-based cancer drug developer.

Van Naarden was chief business officer at Loxo from January 2016 to December 2018 and vice president of corporate development and strategy from May 2014 to December 2015.